 |
Joele Frank represents Aligned Data Centers as it gets acquired by the Artificial Intelligence Infrastructure Partners consortium venture backed by BlackRock’s Global Infrastructure Partners unit, MGX, Microsoft and NVIDIA in a deal valued at $40B.
Dallas-based ADC designs, builds, and operates cutting-edge data campuses and data centers for the world’s premier hyperscalers, neocloud and enterprise innovators.
Its portfolio is located in Northern Virginia, Chicago, Dallas, Ohio, Phoenix, Salt Lake City, Sao Paulo, Santiago and Queretaro (Mexico).
Larry Fink, CEO of BlackRock and chair of AIP, said the investment in ADC, “will further our goal of delivering the infrastructure necessary to power the future of AI, while offering our clients attractive opportunities to participate in its growth.”
Andrew Schaap, CEO of ADC, said he expects the transaction will accelerate its mission to deliver the infrastructure powering tomorrow’s digital economy.
"With AIP, MGX and GIP’s global reach, extensive resources, and deep expertise across AI, energy and finance, we are poised to scale faster, innovate further and redefine what’s possible in sustainable data center infrastructure,” he added.
Joele Frank, Wilkinson Brimmer Katcher partners Aura Reinhard and Andi Rose, and managing directors Lucas Pers, Kate Thompson and Rachel Goldman.
Interpublic posted a 5.1 percent drop in Q3 net revenues to $2.5B as CEO Philippe Krakowsky reports the final financial results of the publicly traded company.
Joele Frank handles Pine Gate Renewables as the Asheville, NC-based solar power development company declares Chapter 11 in the aftermath of Donald Trump’s cuts to wind & solar tax credits.
Stagwell CEO Mark Penn reports Q3 net revenues jumped 6 percent to $614.5M, a record performance for a non-political period. Operating income soared 45.7 percent to $60.9M.
Joele Frank works for Klöckner Pentaplast as the German maker of plastic films declares Chapter 11. A successful reorganization would slash its its corporate debt by $1.5B.
Teneo represents Metsera, the New York City biotech focused on weight-control products, which is subject to a bidding war between heavyweights Novo Nordisk and Pfizer.
